This MedLibrary.org supplementary page on Medroxyprogesterone is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
 |
|
|
Medroxyprogesterone
|
|
| Systematic (IUPAC) name | |
| 17-acetyl-17-hydroxy- 6,10,13-trimethyl- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one | |
| Identifiers | |
| CAS number | |
| ATC code | G03 G03, L02 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C22H32O3 |
| Mol. mass | 344.488 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 90% |
| Metabolism | ? |
| Half life | 50 days |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Medroxyprogesterone is a progestin, and is commonly a component of hormonal contraceptives. It can be used in the treatment of endometriosis, abnormal menstrual bleeding or amenorrhea.[1][2] Possible side effects include weight gain, depression, and irregular menses or amenorrhea.
Progestins lower the risk of estrogen-related cancer of the uterus. This medicine used in combination with estrogen (hormone replacement therapy - HRT) should not be used to prevent heart disease. Two drug combination HRT (estrogen and progestin menopause) can infrequently cause cancer of the breast, heart disease (e.g., heart attack), stroke, dementia, or blood clots in the lung (pulmonary embolism) or leg. Estrogens may also increase the risk of cancer of the ovary. These risks appear to depend on the length of time this combination is used and the amount of estrogen per dose. Therefore, two-drug HRT should be used for the shortest possible length of time at the lowest effective dose, so you obtain the benefits and minimize the chance of serious side effectis from long-term treatment. If you use this drug for an extended period, you should be evaluated at least once a year.
You should not use this medicine during the first 4 months of pregnancy because birth defects may occur. This medicine has not been proven to prevent natural abortions that occur early in the pregnancy. Often, the cause of an early natural abortion is due to a defective female egg. Using this drug does not fix a defective egg and may get in the way of expelling it.
In males, medroxy-progesterone reduces the production of testosterone by the testes and the adrenal glands, which in some males (not all) reduces sex drive. Several states mandate use of medroxy-progesterone acetate, or MPA, for "chemical castration" of convicted rapists and sex offenders.
References
See also
 |
This medical treatment article is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
Wikipedia content modification information:
- This page was last modified on 1 October 2008, at 19:31.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Medroxyprogesterone".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.